Friday 27 May 2022

A Review on Pleural Biopsy for Evaluation of Malignant Pleural Effusion| Chapter 6 | Challenges and Advances in Pharmaceutical Research Vol.3

MPE (malignant pleural effusion) is a common sign of malignancies such as lung, breast, and lymphoma. Because therapy is based on the aetiology, it is crucial to make an etiological diagnosis of MPE patients as soon as feasible. A cytopathological examination of the fluid for malignant cells is the simplest and most sensitive approach for diagnosing malignant pleural effusion (MPE). Even though cytology is a sensitive test, many individuals are missed, needing a pleural histological examination. Invasive techniques such as closed pleura biopsy (CPB) or thoracoscopy were recommended. CPB was once thought to be the investigation of choice in situations of undetected pleural effusion because of its high effectiveness. The use of CPB in the diagnosis of cytology negative MPE has been steadily reducing with the introduction of medical thoracoscopy (MT). Thoracoscopy, on the other hand, is only used in a few number of situations due to its high cost and difficulty. CPB is less accurate than cytopathological evaluation of fluid or MT in determining MPE. Despite this, it is a straightforward procedure with little side effects. The purpose of this study is to look at the clinical signs and symptoms of MPE, as well as the function of CPB in diagnosing MPE and the advantages and disadvantages of CPB.


Author(s) Details:

Reshma S. Babu,
Department of Respiratory Medicine, JNMC, Sawangi (Meghe), Wardha, 442001, India.

Ulhas Jadhav,
Department of Respiratory Medicine, JNMC, Sawangi (Meghe), Wardha, 442001, India.

Pankaj Wagh,
Department of Respiratory Medicine, JNMC, Sawangi (Meghe), Wardha, 442001, India.

Please see the link here: https://stm.bookpi.org/CAPRV-3/article/view/6946

No comments:

Post a Comment